Dear Valued Pawsitive I.D. Customers:

It is with great regret that I must inform you that PinPoint DNA Technologies, Inc must temporarily suspend the inclusion of the PRCD (Progressive Rod-Cone Degeneration) portion of the Pawsitive I.D. Genetic Disease Screening Platform. This is due to the recent issuance of U.S. Patent No. 7,312,037, dated December 25, 2007 which is licensed to one of our competitors. This suspension will take effect as of Midnight April 1, 2008. Anyone who has purchased a test prior to April 1, 2008 will receive full results including the PRCD portion. However, any pre-April 1, 2008 purchased tests must be submitted for processing before May 1, 2008 if inclusion of the PRCD test is needed.

THE SUSPENSION OF THE PRCD PORTION OF THE PAWSITIVE I.D. TEST DOES NOT AFFECT ANY OTHER PORTION OF OUR PRODUCT!

Upon issuance of a cease and desist order from our competitor regarding this patent, PinPoint undertook a comprehensive evaluation of the 037 patent to determine its validity. Although serious issues were uncovered, a prudent business decision has been made not to become engaged in a protracted and expensive legal battle. PinPoint does not believe it has in the past or is currently infringing on the 037 patent or any other patent belonging to any competitor.

From the beginning, PinPoint has been dedicated to bringing cost effective genetic testing to the companion animal industry. And we will continue to do so. PinPoint and its affiliates have pending patents that we believe will allow us to re-commence testing for PRCD in the near future once issued. Our promise to you is that we will continue to work as hard as possible to make our product a valuable, cost effective method of improving the health of dog & cat breeds.

Thank you all for your past, present and future business!!!

Rick Dobbins, CEO
PinPoint DNA Technologies, Inc

Please feel free to call me at 404-367-8400 with any and all questions.